Delivery Order SPE2DE21D0017-SPE2D626F7967
- Not listed
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $2,400.00 delivery order by the Defense Logistics Agency Medical Supply Chain on October 23, 2025, for COVID-19 virus test kits (KIT ID NOW COVID-19 VIR TST 24 TST). The contract utilizes fixed-price pricing with economic price adjustment provisions and is scheduled for completion by October 31, 2025. Performance will be conducted at the company's location in Lockhart, Florida. This delivery order was...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $12,720.00 fixed-price delivery order with economic price adjustment by the Defense Logistics Agency (DLA) Medical Supply Chain on October 15, 2025, with an ultimate completion date of October 21, 2025. The contract, which carries no set-aside designation and indicates open competition, is for a kit identification, now strip A2 qualification detector mobile/mobile laboratory test. Performance will occur in...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, was awarded a $1,344.00 delivery order contract on August 14, 2025, by the Defense Logistics Agency's Medical Supply Chain for diagnostic testing supplies and equipment. The contract, designated as a fixed-price agreement with economic price adjustment, calls for delivery of ID NOW Strep A Qualification Detection Mobile Lab Test kits to Lockhart, Florida, with an ultimate completion date of August 19, 2025. This delivery...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a $14,448 delivery order by the Defense Logistics Agency Medical Supply Chain on October 29, 2025, with performance completion targeted for November 5, 2025. This fixed-price delivery order with economic price adjustment provisions is for ID NOW Strep rapid diagnostic tests, leveraging the company's established expertise in point-of-care testing devices and molecular diagnostic platforms. The award carries...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostic equipment and testing supplies, was awarded a $2,688 fixed-price delivery order with economic price adjustment on June 16, 2025, by the Defense Logistics Agency Medical Supply Chain. The contract, designated as a Kit ID NOW Strep A2 Qual Detect Microbial Test, is scheduled for completion by June 20, 2025, and will be performed in Lockhart, Florida. This delivery order was awarded without a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a fixed-price delivery order valued at $69,600 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The contract, which runs through August 28, 2025, covers ID NOW flu testing supplies and is classified as a Delivery Order with economic price adjustment provisions. The award was made through open competition with no set-aside designation, and performance will occur in Lockhart, Florida....
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories specializing in medical diagnostics, was awarded a $6,000 fixed-price delivery order for ID NOW COVID-19 virus test kits by the Defense Logistics Agency Medical Supply Chain on September 11, 2025. The delivery order, which has no set-aside designation, indicates open competition and carries an ultimate completion date of September 19, 2025. The performance location is identified as Lockhart, Florida. This award represents a...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 5, 2025, for COVID-19 test kits valued at $15,000.00 with a completion date of September 16, 2025. This fixed-price contract with economic price adjustment clauses was awarded without set-aside designation, indicating open competition. The Defense Logistics Agency Medical Supply Chain funded this award, and performance will be completed in Lockhart, Florida. The delivery order...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., has been awarded a delivery order contract valued at $6,000 for COVID-19 test kits by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on September 16, 2025, with an ultimate completion date of September 25, 2025, utilizes a fixed-price structure with economic price adjustment provisions and was awarded without a set-aside designation, indicating full and open competition. Performance of this...
- Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., was awarded a delivery order on September 17, 2025, for COVID-19 diagnostic test kits under contract 4569502136. The order, valued at $3,600.00 with a fixed-price contract type that includes economic price adjustment provisions, is scheduled for completion by September 26, 2025. The products will be delivered to Lockhart, Florida, and the award was made by the Defense Logistics Agency Medical Supply Chain without a...
- SPE2DE21D0017Indefinite Delivery Contract
- SPE2DE21D0017-SPE2D626F7967Delivery Order
Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories Inc., received a delivery order award from the Defense Logistics Agency Medical Supply Chain on October 31, 2025, valued at $1,680.00 with a fixed-price structure and economic price adjustment provisions. The contract, identified as "KIT ID NOW STRP A2 QUAL DTCT MCBLTST 24," represents a delivery order for diagnostic testing kits, specifically ID NOW rapid diagnostic detection systems with associated qualification and materials. Performance will be completed by November 7, 2025, at the contractor's facility in Lockhart, Florida. No small business set-aside designation was applied to this award, allowing full and open competition among potential bidders. This delivery order is issued under an existing indefinite delivery vehicle, reflecting Abbott Rapid DX's established role as a critical supplier of point-of-care diagnostic testing solutions to federal healthcare agencies. The contractor specializes in rapid antigen tests, molecular diagnostic platforms, and related medical testing supplies, with extensive prior performance across multiple Veterans Integrated Service Networks, the Defense Health Agency, and other federal healthcare entities. The modest contract ceiling of $1,680.00 is consistent with typical consumable supply orders issued under the agency's Medical Supply Chain procurement framework, supporting federal healthcare readiness and diagnostic testing capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 10/31/25 |